Skip to main content
SpringerLink
Log in

Single Photon Emission Computed Tomography (SPECT) in Obsessive–Compulsive Disorder Before and After Treatment with Inositol

  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Inositol, a glucose isomer and second messenger precursor, regulates numerous cellular functions and has demonstrated efficacy in obsessive–compulsive disorder (OCD) through mechanisms that remain unclear. The effect of inositol treatment on brain function in OCD has not been studied to date. Fourteen OCD subjects underwent single photon emission computed tomography (SPECT) with Tc-99m HMPAO before and after 12 weeks of treatment with inositol. Whole brain voxel-wise SPM was used to assess differences in perfusion between responders and nonresponders before and after treatment as well as the effect of treatment for the group as a whole. There was 1) deactivation in OCD responders relative to nonresponders following treatment with inositol in the left superior temporal gyrus, middle frontal gyrus and precuneus, and the right paramedian post-central gyrus; 2) no significant regions of deactivation for the group as a whole posttreatment; and 3) a single cluster of higher perfusion in the left medial prefrontal region in responders compared to nonresponders at baseline. Significant reductions in the YBOCS and CGI—severity scores followed treatment. These data are only partly consistent with previous functional imaging work on OCD. They may support the idea that inositol effects a clinical response through alternate neuronal circuitry to the SSRIs and may complement animal work proposing an overlapping but distinct mechanism of action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

references

  • Balla, T., Bondeva, T., and Varnai, P. (2000). How accurately can we image inositol lipids in living cells? Trends Pharmacol. Sci. 21:238-241.

    Google Scholar 

  • Barak, Y., Levine, J., Glasman, A., Elizur, A., and Belmaker, R.H. (1996). Inositol treatment of Alzheimers disease. Prog. Neuoropsychopharmacol. Biol. Psychiatry 20:729-735.

    Google Scholar 

  • Baxter, L.R., Schwartz, J.M., Bergman, K.S., Szuba, M.P., Guze, B.H., Mazziotta, J.C., Alazraki, A., Selin, C.E., Ferng, H.K., Munford, P., and Phelps, M.E. (1992). Caudate glucose metabolic rate changes in both drug and behaviour therapy for obsessive–compulsive disorder. Arch. Gen. Psychiatry 49:681-689.

    Google Scholar 

  • Benjamin, J., Levine, J., Fux, M., Aviv, A., Levy, D., and Belmaker, R.H. (1995). Double blind controlled trial of inositol treatment of panic disorder. Am. J. Psychiatry 52:1084-1086.

    Google Scholar 

  • Benkelfat, C., Nordahl, T.E., Semple, W.E., King, A.C., Murphy, D.L., and Cohen, R.M. (1990). Local cerebral glucose metabolic rates in obsessive–compulsive disorder. Arch. Gen. Psychiatry 47:840-848.

    Google Scholar 

  • Brink, C.B., Viljoen, S.L., de Kock, S.E., Stein, D.J., and Harvey, B.H. (2004). Effects of myo-inositol versus fluoxetine and imipramine pretreatments on serotonin 5HT2A and muscarinic acetylcholine receptors in human neuroblastoma cells. Met. Br. Dis. 19:61-80.

    Google Scholar 

  • Brody, A.L., Saxena, S., Schwartz, J.M., Stoessel, P.W., Maidment, K., Phelps, M.E., and Baxter, L.R. (1998). FDG-PET predictors of response to behavioural therapy and pharmacotherapy in obsessive-compulsive disorder. Psychiatry Res. 84:1-6.

    Google Scholar 

  • Chang, L. (1978). A method for attentuation correction in radionuclide computed tomography. Trans. Nucl. Sci. 25:638-643.

    Google Scholar 

  • De Groot, A., and Treit, D. (2002). Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Brain Res. 949(1–2):60-70.

    Google Scholar 

  • De Groot, A., and Treit, D. (2003). Septal GABAergic and hippocampal cholinergic systems interact in the modulation of anxiety. Neuroscience 117:493-501.

    Google Scholar 

  • Einat, H., and Belmaker, R.H. (2001). The effects of inositol treatment in animal models of psychiatric disorders. J. Affect. Disord. 62:113-121.

    Google Scholar 

  • First, M.B., Spitzer, M.B., Gibbon, R.L., and Williams, J.B.W. (1995). Structured Clinical Interview for DSM IV Axis I Disorders—Clinician Version, Biometrics Research Department. New York State Psychiatric Institute, New York.

    Google Scholar 

  • Fux, M., Benjamin, J., and Belmaker, R.H. (1999). Inositol versus placebo augmentation of serotonin reuptake inhibitors in the treatment of obsessive–compulsive disorder: Double-blind cross-over study. Int. J. Neurpsychopharmacol. 2:193-195.

    Google Scholar 

  • Fux, M., Levine, J., Aviv, A., and Belmaker, R.H. (1996). Inositol treatment of obsessive–compulsive disorder. Am. J. Psychiatry 153:1219-1221.

    Google Scholar 

  • Goodman, W.K., Price, L.H., Rasmussen, S.A., Mazure, C., Fleischman, R.L., Hill, C.L., Heninger, G.R., and Charney, D.S. (1989). The Yale-Brown Obsessive Compulsive Scale. Arch. Gen. Psychiatry 46:1006-1016.

    Google Scholar 

  • Greist, J.H., Jefferson, J.W., Kobak, K.A., Katzelnick, D.J., and Serlin, R.C. (1995). Efficacy and tolerability of serotonin transport inhibitors in obsessive–compulsive disorder. Arch. Gen. Psychiatry 52:53-59.

    Google Scholar 

  • Guy, W. (1976). ECDU Assessment Manual for Psychopharmacology, revised 1976, National Institute of Mental Health, Psychopharmacology Research Branch, pp. 217–222, 313–331.

  • Harvey, B.H., Brink, C.B., Seedat, S., and Stein, D.J. (2002). Defining the neuromolecular action of myo-inositol: Application to obsessive–compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 26:21-32.

    Google Scholar 

  • Hoehn-Saric, R., Pearlson, G.D., Harris, G.J., Machlin, S.R., and Camargo, E.E. (1991). Effects of fluoxetine on regional cerebral blood flow in obsessive–compulsive patients. Am. J. Psychiatry 148:1243-1245.

    Google Scholar 

  • Hoehn-Saric, R., Schlaepfer, T.E., Greenberg, B.D., McLeod, D.R., Pearlson, G.D., and Wong, S.H. (2001). Cerebral blood flow in obsessive–compulsive patients with major depression: Effect of treatment with sertraline or desipramine on treatment responders and nonresponders. Psychiatry Res. Neuroimaging 108:89-100.

    Google Scholar 

  • Hugo, F., van Heerden, B., Zungu-Dirwayi, N., and Stein, D.J. (1999). Functional brain imaging in obsessive–compulsive disorder secondary to neurological lesions. Depress. Anxiety 10:129-136.

    Google Scholar 

  • Jenike, M.A., and Brotman, A.W. (1984). The EEG in obsessive–compulsive disorder. J. Clin. Psychiatry 45(3):122-124.

    Google Scholar 

  • Khanna, S. (1988). Obsessive–compulsive disorder: Is there frontal lobe dysfunction? Biol. Psychiatry 24(5):602-613.

    Google Scholar 

  • Kwon, J.S., Kim, J.J., Lee, D.W., Lee, J.S., Lee, D.S., Kim, M.S., Lyoo, I.K., Cho, M.J., and Lee, M.C. (2003). Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive–compulsive disorder. Psychiatry Res. 122(1):37-47.

    Google Scholar 

  • Levine, J. (1997a). Controlled trials of inositol in psychiatry. Eur. Neuropsychopharmacol. 7:147-155.

    Google Scholar 

  • Levine, J., Aviram, A., Holan, A., Ring, A., Barak, Y., and Belmaker, R.H. (1997b). Inositol treatment of autism. J. Neural Transm. 104:307-310.

    Google Scholar 

  • Levine, J., Barak, Y., Gonsalves, M., Elizur, A., and Belmaker, R.H. (1995). Double blind study of inositol versus placebo in depression. Am. J. Psychiatry 152:792-794.

    Google Scholar 

  • Levine, J., Goldberger, I., Rapoport, A., Schwartz, M., Schields, C., Elizur, A., Belmaker, R.H., Shapiro, J., and Agam, G. (1994). CSF inositol levels in schizophrenia are unchanged and inositol is not therapeutic in anergic schizophrenia. Eur. Neuropsychopharmacol. 4:487-490.

    Google Scholar 

  • Levine, J., Ring, A., Barak, Y., Elizur, A., Kofman, O., and Belmaker, R.H. (1996). Inositol may worsen attention deficit disorder with hyperactivity. Hum. Psychopharmacol. 10:481-484.

    Google Scholar 

  • Mataix-Cols, D., Cullen, S., Lange, K., Zelaya, F., Andrew, C., Amaro, E., Brammer, M.J., Williams, S.C.R., Speckens, A., and Phillips, M.L. (2003). Neural correlates of anxiety associated with obsessive–compulsive symptom dimensions in normal volunteers. Biol. Psychiatry 53(6):482-493.

    Google Scholar 

  • McGuire, P.K., Bench, C.J., Frith, C.D., Marks, I., Frackowiak, R.S., and Dolan, R.J. (1994). Functional neuroanatomy of obsessive–compulsive phenomena. Br. J. Psychiatry 164:459-468.

    Google Scholar 

  • Montgomery, S.A., and Asberg, M.A. (1979). A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134:382-389.

    Google Scholar 

  • Nemets, B., Talesnick, B., Belmaker, R.H., and Levine, J. (2002). Myo-inositol has no beneficial effect on premenstrual dysphoric disorder. World J. Biol. Psychiatry 3:147-149.

    Google Scholar 

  • Palatnik, A., Frolov, K., Fux, M., and Benjamin, J. (2001). Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. J. Clin. Psychopharmacol. 21(3):335-339.

    Google Scholar 

  • Piggot, T.A., and Seay, S.M. (1999). A review of the efficacy of selective serotonin reuptake inhibitors in obsessive–compulsive disorder. J. Clin. Psychiatry 60(2):101-106.

    Google Scholar 

  • Rauch, S.L., Shin, L.M., Dougherty, D.D., Alpert, N.M., Fischman, A.J, and Jenike, M.A. (2002). Predictors of fluvoxamine response in contamination-related obsessive–compulsive disorder: A PET symptom provocation study. Neuropsychopharmacol. 27(5):782-791.

    Google Scholar 

  • Russell, A., Cortese, B., Lorch, E., Ivey, J., Banerjee, S.P., Moore, G.J., and Rosenberg, D.R. (2003). Localised functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive–compulsive disorder. J. Child Adolesc. Psychopharmacol. 13(Suppl. 1):S31-S38.

    Google Scholar 

  • Saxena, S., Brody, A., Ho, M., Zohrabi, N., Maidment, K.M., and Baxter, L.R. (2003). Differential brain metabolic predictors of response to paroxetine in obsessive–compulsive disorder versus major depression. Am. J. Psychiatry 160:522-532.

    Google Scholar 

  • Saxena, S., Brody, A.L., Ho, M.L., Alborzan, S., Maidment, K.N., Zohrabi, I., Ho, M.K., Huang, S.C., Wu, H.M., and Baxter, L.R., Jr. (2002). Differential cerebral metabolic changes with paroxetine treatment of obsessive–compulsive disorder vs major depression. Arch. Gen. Psychiatry 59:250-261.

    Google Scholar 

  • Saxena, S., and Rauch, S.L. (2000). Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Pyschiatr. Clin. North Am. 23:563-586.

    Google Scholar 

  • Schwartz, J.M., Stoessel, P.W., Baxter, L.R., Martin, K.M., and Phelps, M.E. (1996). Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive–compulsive disorder. Arch. Gen. Psychiatry 53:109-113.

    Google Scholar 

  • Seedat, S., and Stein, D.J. (1999). Inositol augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: An open label trial. Int. Clin. Psychopharmacol. 14:353-356.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MRC Research Unit for Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, Tygerberg, Cape Town, South Africa

    P. D. Carey, J. Warwick, D. J. Stein & S. Seedat

  2. Department of Nuclear Medicine, University of Stellenbosch, Tygerberg, South Africa

    J. Warwick

  3. Division of Pharmacology, School of Pharmacy, North West University, Potchefstroom, South Africa

    B. H. Harvey

Authors
  1. P. D. Carey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Warwick
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. H. Harvey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. J. Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Seedat
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carey, P.D., Warwick, J., Harvey, B.H. et al. Single Photon Emission Computed Tomography (SPECT) in Obsessive–Compulsive Disorder Before and After Treatment with Inositol. Metab Brain Dis 19, 125–134 (2004). https://doi.org/10.1023/B:MEBR.0000027423.34733.12

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:MEBR.0000027423.34733.12

Search

Navigation